Simplex Trading
GILD icon

Simplex Trading’s Gilead Sciences GILD Stock Holding History

Simplex Trading’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8M Sell
57,400
-100,700
-64% -$14.1M 0.01% 807
2025
Q4 		$19.4M Sell
158,100
-58,100
-27% -$7.06M 0.01% 562
2025
Q3 		$24M Sell
216,200
-105,500
-33% -$12M 0.01% 569
2025
Q2 		$35.7M Sell
321,700
-228,700
-42% -$24.3M 0.02% 371
2025
Q1 		$61.7M Buy
550,400
+109,600
+25% +$11.3M 0.04% 222
2024
Q4 		$40.7M Sell
440,800
-167,500
-28% -$15.1M 0.02% 370
2024
Q3 		$51M Buy
608,300
+5,700
+0.9% +$435K 0.03% 301
2024
Q2 		$41.3M Buy
602,600
+114,700
+24% +$7.65M 0.03% 352
2024
Q1 		$35.7M Buy
487,900
+67,300
+16% +$5.18M 0.02% 446
2023
Q4 		$34.1M Sell
420,600
-24,000
-5% -$1.87M 0.02% 479
2023
Q3 		$33.3M Buy
444,600
+129,600
+41% +$9.97M 0.03% 401
2023
Q2 		$24.3M Buy
315,000
+95,800
+44% +$7.64M 0.02% 503
2023
Q1 		$18.2M Sell
219,200
-226,700
-51% -$18.8M 0.02% 627
2022
Q4 		$38.3M Sell
445,900
-3,200
-0.7% -$253K 0.04% 341
2022
Q3 		$27.7M Sell
449,100
-122,800
-21% -$7.74M 0.03% 409
2022
Q2 		$35.3M Sell
571,900
-398,600
-41% -$24.7M 0.04% 333
2022
Q1 		$57.7M Sell
970,500
-36,200
-4% -$2.31M 0.05% 256
2021
Q4 		$73.1M Buy
1,006,700
+327,100
+48% +$22.5M 0.07% 205
2021
Q3 		$47M Sell
679,600
-7,800
-1% -$548K 0.04% 256
2021
Q2 		$47.3M Buy
+687,400
New +$45.9M 0.05% 249
2021
Q1 		– Sell
-6,216
Closed -$36.2M – 9227
2020
Q4 		$36.2M Sell
6,216
-1,110
-15% -$67K 0.05% 228
2020
Q3 		$46.3M Buy
7,326
+2,405
+49% +$167K 0.06% 172
2020
Q2 		$37.9M Sell
4,921
-2,735
-36% -$210K 0.06% 175
2020
Q1 		$57.2M Buy
7,656
+1,080
+16% +$74.6K 0.1% 98
2019
Q4 		$42.7M Buy
6,576
+2,721
+71% +$177K 0.09% 129
2019
Q3 		$24.4M Buy
3,855
+4
+0.1% +$261 0.07% 208
2019
Q2 		$26M Buy
3,851
+1,188
+45% +$78.2K 0.07% 186
2019
Q1 		$17.3M Sell
2,663
-568
-18% -$37.8K 0.05% 256
2018
Q4 		$20.2M Sell
3,231
-155
-5% -$10.8K 0.06% 200
2018
Q3 		$26.1M Buy
3,386
+333
+11% +$25.1K 0.08% 165
2018
Q2 		$21.6M Buy
3,053
+788
+35% +$55.6K 0.08% 164
2018
Q1 		$1.07M Sell
2,265
-3,111
-58% -$247K 0.05% 371
2017
Q4 		$1.73M Buy
5,376
+89
+2% +$6.76K 0.07% 217
2017
Q3 		$1.37M Sell
5,287
-2,360
-31% -$180K 0.06% 278
2017
Q2 		$2.43M Sell
7,647
-5,241
-41% -$349K 0.11% 148
2017
Q1 		$5.26M Buy
12,888
+6,530
+103% +$459K 0.23% 74
2016
Q4 		$3.81M Buy
6,358
+296
+5% +$22K 0.23% 77
2016
Q3 		$3.9M Buy
6,062
+2,612
+76% +$212K 0.26% 61
2016
Q2 		$2.79M Sell
3,450
-339
-9% -$30.1K 0.19% 86
2016
Q1 		$2.04M Buy
3,789
+4
+0.1% +$361 0.16% 110
2015
Q4 		$2.12M Sell
3,785
-3,794
-50% -$395K 0.17% 103
2015
Q3 		$6M Buy
7,579
+3,205
+73% +$356K 0.44% 41
2015
Q2 		$1.05M Sell
4,374
-1,505
-26% -$164K 0.09% 205
2015
Q1 		$1.97M Sell
5,879
-1,965
-25% -$200K 0.23% 84
2014
Q4 		$4.04M Buy
+7,844
New +$811K 0.49% 26

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Simplex Trading's GILD Position: Q3 2025 in Review

Simplex Trading sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 26,577 shares — an estimated $3.02M sold.

Simplex Trading first reported a position in GILD in Q4 2014 and held it in 33 quarters. The position peaked at $32.5M in Q1 2017. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Simplex Trading reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 26,577 Gilead Sciences shares in Q3 2025, an estimated $3.02M.
  • Simplex Trading first reported a position in Gilead Sciences in Q4 2014 and held it in 33 quarters.
  • Simplex Trading's Gilead Sciences position peaked at $32.5M in Q1 2017.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.